We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
51 hedge funds and large institutions have $22.4M invested in CASI Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.77% less ownership
Funds ownership: 2.77% → 2% (-0.77%)
12% less funds holding
Funds holding: 58 → 51 (-7)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
51% less capital invested
Capital invested by funds: $46M → $22.4M (-$23.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
51
Holders Change
-7
Holders Change %
-12.07%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
9
Reduced
15
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$1.86M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$774K |
| 3 |
WSC
Wellington Shields & Co
New York
|
-$689K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$649K |
| 5 |
Millennium Management
New York
|
-$431K |
